1.1. Analysis.
Comparison 1 Long‐acting muscarinic antagonists (LAMA) add‐on versus long‐acting beta2‐agonists (LABA) add‐on, Outcome 1 Exacerbations (oral corticosteroid).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.